Michael Aaron Kelly - 27 May 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
27 May 2025
Net transactions value
+$38,000
Form type
4
Filing time
28 May 2025, 16:07:40 UTC
Previous filing
15 May 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelly Michael Aaron Director 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 28 May 2025 0001769668

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Purchase $38,000 +5,000 $7.60 5,000 27 May 2025 M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016
holding NEO Common Stock 31,755 27 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 2,223 27 May 2025 Common Stock 2,223 $37.53 Direct
holding NEO Stock Option (Right to Buy) 3,714 27 May 2025 Common Stock 3,714 $40.90 Direct
holding NEO Stock Option (Right to Buy) 13,882 27 May 2025 Common Stock 13,882 $8.10 Direct
holding NEO Stock Option (Right to Buy) 8,353 27 May 2025 Common Stock 8,353 $14.82 Direct
holding NEO Stock Option (Right to Buy) 8,672 27 May 2025 Common Stock 8,672 $13.71 Direct
holding NEO Restricted Stock Unit 12,254 27 May 2025 Common Stock 12,254 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.